Publications

All      Ay      Benedict       Cheroutre       Croft       Crotty      Einav       Grifoni       Hogan       Kronenberg      Lisdestam Arlehamn      Myers      Peters      Rao      Reina      Saphire      Schmiedel      Schoenberger      Sette      Sharma      Shresta      Vijayanand      Weiskopf
Altman             Eschweiler      Hedrick       Kawakami      Ley      Pandurangan      Seumois      Von Herrath      
Mar 29, 2012
  • PLoS One

The role of fibrocytes in sickle cell lung disease

Field JJ, Burdick MD, Debaun MR, Strieter BA, Liu L, Mehrad B, Rose CE Jr, Linden J, Strieter RM
Mar 21, 2012
  • BMC Bioinformatics

Metabolic Network Alignment in Large Scale by Network Compression.

F. Ay, M. Dang and T. Kahveci
Mar 3, 2012
  • PLoS Pathog

The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold.

Zhang AP, Bornholdt ZA, Liu T, Abelson DM, Lee DE, Li S, Woods VL Jr, Saphire EO.
Mar 1, 2012
  • Journal of Immunology

Structural and functionlal characterization of a novel nonglycosidic type 1 NKT agonist with immunomodulatory properties

Kerzerho J, Yu ED, Barra CM, Alari-Pahisa E, Girardi E, Harrak Y, Lauzurica P, Llebaria A, Zajonc DM, Akbari O, Castaño AR
Mar 1, 2012
  • Expert Review of Anti-infective Therapy

Can an immune-regulatory vaccine prevent HIV infection?

Boettler T, Cunha-Neto E, Kalil J, von Herrath M
Mar 1, 2012
  • Clinical Immunology

Combination therapy with InsB9-23 peptide immunization and CTLA4-IgG does not reverse diabetes in NOD mice

Schneider DA, Sarikonda G, von Herrath MG
Mar 1, 2012
  • Stem Cells

RNA-binding protein L1TD1 interacts with LIN28 via RNA and is required for human embryonic stem cell self-renewal and cancer cell proliferation

Närvä E, Rahkonen N, Emani MR, Lund R, Pursiheimo JP, Nästi J, Autio R, Rasool O, Denessiouk K, Lähdesmäki H, Rao A, Lahesmaa R
Mar 1, 2012
  • Blood

Human FcyRIIA at center stage

Kawakami T
Mar 1, 2012
  • Annals of Allergy Asthma & Immunology

Omalizumab inhibits acceleration of FceRI-mediated responsiveness of immature human mast cells by immunoglobulin EOmalizumab inhibits acceleration of FceRI-mediated responsiveness of immature human mast cells by immunoglobulin EOmalizumab inhibits acceleration of FceRI-mediated responsiveness of immature human mast cells by immunoglobulin EOmalizumab inhibits acceleration of FceRI-mediated responsiveness of immature human mast cells by immunoglobulin E

Okayama Y, Kashiwakura J, Sasaki-Sakamoto T, Matsumoto K, Hashimoto N, Ohmori K, Kawakami T, Saito H, Ra C
Mar 1, 2012
  • Trends in Immunology

TNF superfamily in inflammatory disease: translating basic insights

Croft M, Duan W, Choi H, Eun SY, Madireddi S, Mehta A
Mar 1, 2012
  • Journal of Immunology

Alternaria induces STAT6-dependent acute airway eosinophilia and epithelial FIZZ1 expression that promotes airway fibrosis and epithelial thicknessAlternaria induces STAT6-dependent acute airway eosinophilia and epithelial FIZZ1 expression that promotes airway fibrosis and epithelial thicknessAlternaria induces STAT6-dependent acute airway eosinophilia and epithelial FIZZ1 expression that promotes airway fibrosis and epithelial thickness

Doherty TA, Khorram N, Sugimoto K, Sheppard D, Rosenthal P, Cho JY, Pham A, Miller M, Croft M, Broide DH
Mar 1, 2012
  • Expert Review of Clinical Immunology

PKCQ: a new target for selective immunosuppression

Altman A, Kong KF